Center For Sight Implants New FDA-Approved iDose®TR Device [Yahoo! Finance]
Glaukos Corporation (GKOS)
Last glaukos corporation earnings: 2/27 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.glaukos.com/investors/investor-overview/default.aspx
Company Research
Source: Yahoo! Finance
the first iDoseTR implant surgery in the state of Florida since the device was approved by the Food and Drug Administration in December, 2023. The iDoseTR implant, manufactured by Glaukos Corporation, is a sustained release ophthalmic implant that is surgically placed in the eye. The device consistently distributes a travoprost formula to help reduce intraocular pressure in patients with ocular hypertension or open-angle glaucoma. Glaucoma is a progressive disease in which fluid in the eye cannot drain well. This increase in intraocular pressure causes damage to the optic nerve, resulting in vision loss. Joshua Kim, M.D. is a member of the US Eye Physician Advisory Board and is a Cataract and Glaucoma Surgeon at Center For Sight. Additionally, he serves as the Director of Glaucoma Services for the practice. Dr. Kim implanted the device, as he was a principal investigator in the iDoseTR FDA Phase II and III trials for many years leading up to the FDA approval. Speaking of the dev
Show less
Read more
Impact Snapshot
Event Time:
GKOS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GKOS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GKOS alerts
High impacting Glaukos Corporation news events
Weekly update
A roundup of the hottest topics
GKOS
News
- Glaukos Announces the Release of its 2023 Sustainability Report [Yahoo! Finance]Yahoo! Finance
- Glaukos Announces the Release of its 2023 Sustainability ReportBusiness Wire
- Here's Why You Should Retain Glaukos (GKOS) Stock for Now [Yahoo! Finance]Yahoo! Finance
- Glaukos (GKOS) Gains Nearly 25% YTD: What's Driving the Rally? [Yahoo! Finance]Yahoo! Finance
- Is Now The Time To Look At Buying Glaukos Corporation (NYSE:GKOS)? [Yahoo! Finance]Yahoo! Finance
GKOS
Earnings
- 2/21/24 - Miss
GKOS
Sec Filings
- 4/16/24 - Form DEF
- 4/16/24 - Form ARS
- 4/16/24 - Form DEFA14A
- GKOS's page on the SEC website